Impact of plaque imaging by electron beam tomography on the treatment of dyslipidemias

Electron beam tomography identifies patients at risk for coronary events with a power multiplicative of standard risk factors. It will have a major impact on the initiation of drug therapy, the identification of treatable metabolic disorders, and the evaluation of the response to treatment.

Saved in:
Bibliographic Details
Published inThe American journal of cardiology Vol. 88; no. 4; pp. 406 - 408
Main Author Hecht, Harvey S
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 15.08.2001
Elsevier Limited
Subjects
Calcium - analysis
Cardiovascular disease
Cholesterol, LDL - blood
Coronary Artery Disease - diagnostic imaging
Coronary Artery Disease - metabolism
Coronary Vessels - chemistry
Health risk assessment
Humans
Hyperlipidemias - drug therapy
Hyperlipidemias - prevention & control
Hypolipidemic Agents - therapeutic use
Medical screening
Tomography, X-Ray Computed - methods
Online AccessGet full text

Cover

More Information
Summary:Electron beam tomography identifies patients at risk for coronary events with a power multiplicative of standard risk factors. It will have a major impact on the initiation of drug therapy, the identification of treatable metabolic disorders, and the evaluation of the response to treatment.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:0002-9149
1879-1913
DOI:10.1016/S0002-9149(01)01688-5